AstraZeneca COVID-19 vaccine arrives

News

18 Nov 2021
AstraZeneca vaccine

AstraZeneca has arrived. We have 100,000 doses in New Zealand that can be used from 29 November.

Pfizer continues to be the main COVID-19 vaccine we are using but AstraZeneca is available for people aged 18 and older who cannot have the Pfizer vaccine or people who want to have a different COVID-19 vaccine.

AstraZeneca is a two-dose viral vector COVID-19 vaccine, with a 4 to 12-week gap between dose 1 and dose 2. Work is underway to provide workforce training and distribution logistics for the vaccination programme.

AstraZeneca COVID-19 vaccine doses will be available at selected vaccination sites and people can book in for an appointment to receive it from 26 November on bookmyvaccine.covid19.health.nz/.

Our doses of the AstraZeneca COVID-19 vaccine have come from the Australian manufacturing site for use in New Zealand.

Medsafe approved the AstraZeneca COVID-19 vaccine in July 2021 for people aged 18 and older and has subsequently approved Australia as a manufacturing site for the vaccine.

Courses on vaccination using the AstraZeneca COVID-19 vaccine will be available soon.

AstraZeneca COVID-19 vaccine

Ministry of Health resources:

AstraZeneca COVID-19 general information
AstraZeneca Vaccine Policy Statement

Last updated: 25 November 2021